Delivery Order SPE2DB24D2106-SPE2DB25FAWCG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,489.92 by the Defense Logistics Agency on July 30, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 ml. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- This is a $31,320.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with an ultimate completion date of September 21, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $59,892.38 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand nine hundred fifty-seven dollars and fifty-three cents ($1,957.53) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025. Under...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,610.08 and covers the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialized pharmaceutical product, with a performance period ending on March 29, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,856.31 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $15,829.17, is a firm fixed-price delivery order for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,955.19 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,520.50 firm fixed-price delivery order is for Humira (CF) Pen 40 mg/0.4 mL, a prescription biologic medication, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- This federal contract award, valued at $32,628.10, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWCGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,958.88 on August 21, 2025, for HUMIRA (adalimumab) pens containing 40 mg/0.4 mL. The order, with an ultimate completion date of August 22, 2025, was issued by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance of the delivery will take place in Conshohocken, Pennsylvania. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026, which authorizes the issuance of firm fixed-price orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The Defense Logistics Agency, operating under the Department of Defense, relies on prime contractors like DMS Pharmaceutical Group to maintain critical pharmaceutical supply chains for military medical facilities. HUMIRA is a widely prescribed biologic medication used to treat autoimmune conditions, and its inclusion in this delivery order reflects the ongoing pharmaceutical needs of military healthcare systems. DMS Pharmaceutical Group has established itself as a significant supplier in federal procurement through consistent contract performance across diverse pharmaceutical categories including biologics, specialty medications, and medical consumables, positioning the company as a key participant in supporting Defense Department healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/21/25 |